Novartis

Novartis is the kind of pharmaceutical company people think of for prescription medicines, especially when the job is long, regulated development rather than quick consumer sales. By our assessment, its strength is breadth: it works across major therapy areas and is known for serious research, large-scale drug development, and a stable place in global pharma. The downside is the one that comes with that whole industry: the output is hard to read from the outside, and the path from lab to patient is slow and tightly controlled. In practice, Novartis is not a flashy brand so much as a complex engine of trials, approvals, and specialist medicines. Compared with smaller biotech firms, it sits on the large, established side of the field. That makes it a fit for people who want a deep, mainstream pharma name, not for anyone expecting a simple, consumer-facing business. It is based in Switzerland.